Systematic evolution of ligands by exponential enrichment
Template:Infobox laboratory technique
Systematic evolution of ligands by exponential enrichment (SELEX) is an in vitro selection technique used to identify nucleic acid ligands, known as aptamers, that have a high affinity for specific target molecules. This method is widely used in molecular biology, biochemistry, and biotechnology for the development of diagnostic and therapeutic agents.
History[edit | edit source]
The SELEX process was independently developed by two research groups in 1990. The technique has since become a fundamental tool in the field of molecular evolution and has been adapted for various applications, including the development of biosensors, drug delivery systems, and targeted therapies.
Process[edit | edit source]
The SELEX process involves several iterative steps:
- **Library Preparation**: A large library of random oligonucleotides is synthesized. These oligonucleotides can be composed of DNA, RNA, or modified nucleic acids.
- **Binding**: The library is incubated with the target molecule, allowing potential aptamers to bind to the target.
- **Partitioning**: Bound oligonucleotides are separated from unbound ones. This can be achieved through various methods such as affinity chromatography, filtration, or magnetic separation.
- **Amplification**: The bound oligonucleotides are amplified using polymerase chain reaction (PCR) for DNA or reverse transcription followed by PCR for RNA.
- **Iteration**: The amplified oligonucleotides are subjected to additional rounds of binding, partitioning, and amplification to enrich the pool for high-affinity aptamers.
Applications[edit | edit source]
SELEX has numerous applications in both research and clinical settings:
- **Diagnostics**: Aptamers selected through SELEX can be used in biosensors for the detection of various biomarkers.
- **Therapeutics**: Aptamers can be developed as therapeutic agents to target specific proteins or cells in diseases such as cancer and viral infections.
- **Research Tools**: Aptamers can be used to study protein-protein interactions, cell signaling pathways, and other biological processes.
Advantages[edit | edit source]
SELEX offers several advantages over traditional methods of ligand discovery:
- **Specificity**: Aptamers can be selected to bind with high specificity to their target molecules.
- **Versatility**: The SELEX process can be adapted to select aptamers for a wide range of targets, including small molecules, proteins, and even whole cells.
- **Stability**: Aptamers are generally more stable than antibodies and can be easily modified to enhance their properties.
Limitations[edit | edit source]
Despite its advantages, SELEX also has some limitations:
- **Complexity**: The SELEX process can be time-consuming and requires specialized equipment and expertise.
- **Cost**: The synthesis and amplification of large oligonucleotide libraries can be expensive.
- **Target Accessibility**: Some targets may be difficult to access or present in low abundance, complicating the selection process.
See also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD